Overview
- 3 FDA inspections are on record.
- 2 inspections produced a Form 483.
- The most recent recorded inspection date is 2025-04-10.
At a glance
Inspections
3
Form 483s
2
EIRs
0
Last outcome
Form 483
Inspection history
FDA inspections on record, most recent first.
| Inspection | Category | Outcome | Form 483 |
|---|---|---|---|
| 24 Mar 2025 – 10 Apr 2025 | Human Drugs | 483 | On file |
| 22 Aug 2022 – 26 Aug 2022 | Human Drugs | 483 | View 483 → |
| 28 May 2019 – 31 May 2019 | Human Drugs | Clean |
Observations on record
Form 483 observations cited at this site, most recent first.
26 Aug 2022
21 CFR 820.100(a)
Lack of or inadequate procedures
Cited by Tyler R Courtney, Shelby N Turner
26 Aug 2022
21 CFR 820.100(a)
Lack of or inadequate procedures
Cited by Tyler R Courtney, Shelby N Turner
Investigators
FDA investigators tied to this site in the record.
Laurimer Kuilan-Torres1 insp.
Yiwei Li1 insp.
Tyler R Courtney1 insp.
Shelby N Turner1 insp.
Seneca D Toms1 insp.
Marla A Cassidy1 insp.
Recurring citations
CFR citation patterns observed across this site's inspections.
| Citation | What it covers | Cited |
|---|---|---|
| 21 CFR 820.100(a) | Cited across public-safe Form 483 observations | 2x |
Full site report
Get the verbatim findings behind Aurolife Pharma LLC's 2 Form 483s
Source PDFs and recurring CFR citations, so your team knows what this site gets cited for.
- The site's full inspection history, with every Form 483 and its outcome
- Warning letters and recalls tied to the company behind it
- Whether recurring CFR citations get closed out or repeat